an alle, die Interesse an Kraft und Muskelmasse haben

kurt schrieb:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14977422&query_hl=4

auf diesen übersichtsartikel hat mich "Bon" hingewiesen, wofür ich mich bedanke. man kann den gesamten text herunterladen.

gruß, kurt
Da bist du glaub ich bevorzugt, ich kann nur den Abstract lesen, für den Artikel müsst ich einiges berappen :(

Aber du könntest ja eine kurze Zusammenfassung abgeben, dann wird auch mein Englisch nicht überstrapaziert :D

Passt heute 17 Uhr an der üblichen Kreuzung?
 
Dimitri schrieb:
Da bist du glaub ich bevorzugt, ich kann nur den Abstract lesen, für den Artikel müsst ich einiges berappen :(

Aber du könntest ja eine kurze Zusammenfassung abgeben, dann wird auch mein Englisch nicht überstrapaziert :D

Passt heute 17 Uhr an der üblichen Kreuzung?

passt!
zum paper: du brauchst nur auf das icon unterhalb von "Annu Rev Physiol. 2004;66:799-828" zu klicken.

cu, kurt
 
kurt schrieb:
passt!
zum paper: du brauchst nur auf das icon unterhalb von "Annu Rev Physiol. 2004;66:799-828" zu klicken.

cu, kurt
Weiß ich schon, aber bei mir kommt dannach nur nochmal der Abstract und zwei Links für Full Text oder PDF. Drückt man da allerdings drauf, dann steht bei mir, dass ich für den Artikel 20 Dollar hinlegen muss. Vielleicht hat bei dir ja die Klinik schon ein Abo bezogen und du kannst deshalb gratis die Artikel lesen.

Gruazi :)
 
Dimitri schrieb:
Weiß ich schon, aber bei mir kommt dannach nur nochmal der Abstract und zwei Links für Full Text oder PDF. Drückt man da allerdings drauf, dann steht bei mir, dass ich für den Artikel 20 Dollar hinlegen muss. Vielleicht hat bei dir ja die Klinik schon ein Abo bezogen und du kannst deshalb gratis die Artikel lesen.

Gruazi :)

so wird es ein. dienstleistung der TILAK:).
aber ich kopier die die publikation und bring sie dir heut mit.

cu, kurt

p.s.: 20 "bucks" is really heavy! :eek:
du könntest die arbeit auch über die uni-bibliothek beziehen.
 
Schade, aber 20 Dollar ist mir der Spaß nicht wert.

Trotzdem danke.

Vielleicht eine kleine Zusammenfassung? (Ich Bettler ;) ).

Gruß
Sascha
 
Danke lieber Kurt. Gibt es aber auch eine Version auf Deutsch? Mein Englisch ist nicht so toll:-(

Liebe Grüsse
Barbara
 
Widar schrieb:
Schade, aber 20 Dollar ist mir der Spaß nicht wert.

Trotzdem danke.

Vielleicht eine kleine Zusammenfassung? (Ich Bettler ;) ).

Gruß
Sascha

die zusammenfassung steht im abstract. es sind noch einige fragen offen...
welche uni ist in deiner nähe? besorg dir das paper über die uni-bibliothek, das kostet dich fast nichts.

gruß, kurt
 
barbara schrieb:
Danke lieber Kurt. Gibt es aber auch eine Version auf Deutsch? Mein Englisch ist nicht so toll:-(

Liebe Grüsse
Barbara

leider gibt es die nicht. wissenschaftliche studien werden auf englisch publiziert (zumindest die, die in "medline" gelistet sind)

lg, kurt
 
Hi Kurt!

Ich hab leider auch keinen freien Zugriff aus das Journal.
Vielleicht kannst du den Artikel ja einfach hier rein kopieren?
 
hier ist der volle Text (erster Teil)

der text hat 99680 zeichen, ein posting kann nur 10000 zeichen fassen - also muss ich es auf raten kopieren.

Full Text
Annual Review of Physiology
Vol. 66: 799-828 (Volume publication date March 2004)
(doi:10.1146/annurev.physiol.66.052102.134444)

First posted online on September 22, 2003

Control of the Size of the Human Muscle Mass
Michael J. Rennie,1,4 *Henning Wackerhage,1 *Espen E. Spangenburg,3 and *Frank W. Booth2*

1Division of Molecular Physiology, School of Life Sciences, University of Dundee, Dundee, DD1 4HN, Scotland, United Kingdom; email: michael.rennie@nottingham.ac.uk; h.wackerhage@dundee.ac.uk

2Department of Biomedical Sciences, Medical Pharmacology and Physiology, and Dalton Cardiovascular Center, University of Missouri-Columbia, Columbia, Missouri 65211; email: boothf@missouri.edu

current addresses: 3Exercise Biology Program, University of California, Davis, California 95616; email: spangenburge@missouri.edu (current: eespangenburg@ucdavis.edu),

4University of Nottingham, Graduate Entry Medical School, City Hospital, Derby, DE22 3NE, United Kingdom

ABSTRACT

This review is divided into two parts, the first dealing with the cell and molecular biology of muscle in terms of growth and wasting and the second being an account of current knowledge of physiological mechanisms involved in the alteration of size of the human muscle mass. Wherever possible, attempts have been made to interrelate the information in each part and to provide the most likely explanation for phenomena that are currently only partially understood. The review should be of interest to cell and molecular biologists who know little of human muscle physiology and to physicians, physiotherapists, and kinesiologists who may be familiar with the gross behavior of human muscle but wish to understand more about the underlying mechanisms of change.

INTRODUCTION

Great strides have been made recently in understanding the regulation of the size of the muscle mass in humans. Dual X-ray absorptiometry (DEXA) (1, 2) and magnetic resonance imaging (MRI) (35), together with advances in immunohistochemical muscle fiber typing (6), have allowed the size of the human muscle mass and its components to be defined with previously unparalleled precision and sensitivity. We are now able to follow accurately small, relatively slow changes in muscle size during the extended timescales of sarcopenia (7, 8) and hypertrophy (9). The application of stable isotope tracer technology to the study of amino acids has markedly increased our knowledge of their transport and intermediary metabolism and protein turnover in skeletal muscle (1013), and positron emission spectroscopy (PET) promises to provide additional information (14). In parallel, ever more signal transduction pathways involved in the regulation of muscle growth are being elucidated, and powerful microarray methods enable identification of genes whose transcription is altered during muscle growth (15). The explosion of knowledge of the molecular cell biology of skeletal muscle (16, 17) has provided us with concepts, techniques, and reagents with which to probe the mechanisms underlying the observed changes in muscle mass in response to altered nutrition and physical activity.1

Hitherto, research on the human muscle mass and muscle growth signaling has usually been conducted by separate groups of researchers with limited mutual communication. The aim of this article is to review both areas and to show connections between them. We first discuss recent findings on muscle growth mechanisms; we then relate these findings to muscle growth in humans.


(fortsetzung folgt)
 
teil 2

MUSCLE GROWTH MECHANISMS - SIGNAL TRANSDUCTION AND REGULATION OF PROTEIN TURNOVER

The specific aim of the first section is to review (a) the signal transduction pathways that sense the muscle's environment and respond to various factors within it, inputting upstream signals to the muscle growth regulation system; (b) the transcriptional regulation of myostatin and IGF-1/MGF expression in response to growth-inducing stimuli; and (c) the specific regulation of muscle growth via regulation of mRNA translation and satellite cell proliferation in response to myostatin, IGF-1/MGF, and other factors. Most of the research has been carried out in nonhuman species, but the results are likely to be relevant to the observations made in human muscle.

Sensing of Growth Stimuli and Transcriptional Regulation

Strenuous, growth-inducing muscle activity is associated with changes in one or more of variables such as passive- and contraction-induced strain, sarcoplasmic calcium concentration, energy demand, intramuscular oxygen concentration, availability of hormones, growth factors and cytokines, temperature, and cellular damage (see Figure 1). A sufficient change in any of these variables will result in the altered activity of signal transduction pathways that regulate the transcription of genes differentially expressed during muscle growth. Signal transduction pathways shown to be activated in response to various forms of muscle contraction include those involving AMPK (18), calcineurin (19), ERK1/2 and p38 (20), JNK (20, 21) NF-B (22), PI3K-PKB/AKT-mTOR (23), and PKC (24). In addition to these pathways, many of the transcription factors involved in myogenesis (25, 26) continue to be active in adaptive and regenerative processes in adult muscle. Thus, strenuous, growth-inducing muscle activity and other growth stimuli are likely to activate a signal transduction network rather than just one or two signal transduction pathways. Skeletal muscle hypertrophy signaling appears to mirror, to some extent, that observed during cardiac hypertrophy (27, 28). Here, we focus on the calcineurin and mechanical-chemical transduction pathways because these two signaling systems have been shown to be involved in muscle growth signaling.


View larger version (33K)

Figure 1
Overview of the main events during signal transduction and gene regulation leading to muscle hypertrophy. (1) Via receptor binding and cellular signals, cytokines and other growth factors are sensed and activate a network of signal transduction pathways that result (2) in the nuclear translocation or activation of transcription factors. Active, nuclear transcription factors (together with androgens and glucocorticoids via their soluble receptors) change the expression of the major muscle growth regulators IGF-1/MGF and myostatin or other muscle genes including ribosomal RNA (rRNA). Pathways that regulate translation or satellite cell function may also be activated by mechanisms other than IGF-1/MGF or myostatin (not shown). (3) IGF-1/MGF and insulin activate the PI3K-PKB/AKT-mTOR pathway, which enhances protein synthesis via increased translational initiation and the synthesis of ribosomal proteins for ribosome biogenesis. Availability of essential amino acids will activate mTOR signaling, whereas an increased energy demand sensed by AMPK will inhibit mTOR. (4) IGF-1/MGF, myostatin, and various other factors regulate an increased proliferation and differentiation of satellite cells.

CALCINEURIN-SIGNALING Ca2+ acts as a regulatory signal during skeletal muscle hypertrophy (29) and is of particular interest because during contraction there is a large transient change in cytosolic Ca2+. Calcineurin is a Ca2+-calmodulin-activated protein phosphatase that dephosphorylates the transcription factor NFAT, enabling its nuclear translocation and DNA binding. The calcineurin pathway has been linked not only to the regulation of skeletal muscle bulk growth but also to that of fast-to-slow phenotype conversion (30) and IGF-1 and Ca2+-induced skeletal muscle hypertrophy, at least in cultured skeletal muscle (31).

However, regulation of nuclear Ca2+ concentrations may occur independently of transient changes in cytoplasmic Ca2+ calcium concentrations (32). In heart, Ca2+-mediated cardiac muscle hypertrophy is induced partly through capacitative Ca2+ entry from the extracellular space by the way of transient receptor potential (Trp) proteins (33). It is not yet clear to what extent such a situation could occur in skeletal muscle, in which a much smaller proportion of Ca2+ flux arises via the sarcoplasmic reticulum. However, it seems likely that Ca2+ may be differentially routed toward nuclear Ca2+-induced gene transcription, inducing activation of the Ca2+-sensitive transcription factor (NFAT).

Activation of NFAT transcriptional signaling is mediated by Ca2+-induced increases in the phosphatase activity of calcineurin, which induces translocation of cytoplasmic NFAT to the nucleus (34). Overexpression of NFAT in transgenic mice results in cardiac hypertrophy and its knockout prevents it (35, 36). NFAT overexpression also results in inactivation of glycogen synthase kinase-3, which mediates the nuclear location of NFAT (37) and possibly induces skeletal myotube hypertrophy (38).

With regard to skeletal muscle hypertrophy in animal models, the role of calcineurin remains controversial owing to the use of cyclosporin A, a nonspecific inhibitor of calcineurin. Inhibition of the calcineurin pathway in vivo with cyclosporin A prevents overload hypertrophy (39). Interestingly, overexpression of calcineurin in transgenic mice does not induce skeletal muscle hypertrophy (40, 41), which may indicate that skeletal muscle already contains sufficient calcineurin activity for muscle growth, and thus the addition of a constitutively active calcineurin is redundant (39). This contention is supported by the finding that cyclosporin blocked the growth of plantaris muscle after induced atrophy, which is noteworthy because the study clearly demonstrated that inhibition of calcineurin with cyclosporine is dependent upon the appropriate concentration of cyclosporine, the muscle, and selection of appropriate time points. Current thought suggests that the hyperactivation of calcineurin alone is not sufficient to induce skeletal muscle hypertrophy but that activation of various upstream or downstream regulators in conjunction with calcineurin activation may play a significant role in muscle hypertrophy (40).

(fortsetzung folgt)
 
teil 3

MECHANICAL-CHEMICAL TRANSDUCTION Nearly 30 years ago, Goldberg et al. summarized their work demonstrating that muscular activity appears to the fundamental determinant of muscle mass (42). This concept has been extended and reinforced by more recent workers: Various sensors of mechanical strain seem to possess the ability to translate strain into chemical signals that induce the activation of the skeletal muscle -actin promoter (43). The existence of a mechano-transduction mechanism in skeletal muscle is reinforced by the tensegrity hypothesis (44), which suggests that a protein framework within the cell maintains its overall cellular architecture; in response to mechanical forces, cell structural networks interact with gene and protein signaling networks to allow cytoskeletal proteins to reposition and renew themselves, permitting the cell to resist deformation from the applied forces. A possible candidate sensor of the increase in mechanical strain is focal adhesion kinase (FAK), a protein localized to the sacrolemma (45, 46); FAK autokinase activity increases during high mechanical loading. In addition, during mechanical loading of muscles, there are significant increases in both the total amount of FAK and its tyrosine phosphorylation status (47). The transcription factor, serum response factor (SRF), is a substrate of FAK, thereby providing a transcriptional link between membrane, the genome, and subsequent expression of muscle protein (43). Furthermore, binding of SRF to the serum response element (SRE1) within the chicken skeletal -actin promoter is both necessary and sufficient for increased transcriptional activity of the skeletal -actin promoter (46). The putative link between FAK and SRF has been strengthened by results indicating that SRF-mediated, skeletal -actin promoter activity is dependent upon activation of 1D-integrin-RhoA signaling and that this activity can be completely abolished by cotransfection of a dominant-negative FAK, termed FRNK (48).

Different modes of exercise affect extracellular signal-regulated kinase (ERK1/2) and the 38-kDa stress-activated protein kinase (p38) in an almost universal way (20, 49) that seems to be intensity dependent. However, only those stimuli likely to result in hypertrophy, such as high-frequency electrical stimulation, increased p70S6 kinase and protein kinase B phosphorylation (49). In a study designed to untangle the effects of concentric and eccentric contractions on the phosphorylation of ERK1/2 and p38, Wretman and coworkers applied a panoply of stimuli to isolated rat extensor digitorum longus muscle in vitro: These included electrically stimulated concentric (shortening) or eccentric (lengthening) contractions or severe passive stretch, and application of antioxidants likely to counteract reactive oxygen species and induce intracellular acidosis (50). They concluded that mechanical activity, whether through contraction or stretch, increased the activity of both ERK1/2 and p38, whereas the ionic changes and increase in reactive oxygen species and acidosis exhibited after concentric contraction increased phosphorylation only of ERK1/2. This suggested that high mechanical stress was required for activation of p38. Because stretch per se does not appear to increase MPS in human muscle (see below), and because changes in ERK1/2 are common to types of exercise that differ markedly in their sequelae (hypertrophy or mitochondrial biogenesis), the likelihood of these signaling molecules being involved in hypertrophy is lessened.


TRANSCRIPTIONAL REGULATION Most of the cellular signaling pathways discussed above control the location and activity of transcription factors that, in turn, regulate gene transcription. However, for many years the processes of protein turnover in skeletal muscle were thought to be modulated without requiring extensive gene expression, which, when it did occur, was considered a relatively sluggish process with a long latency, possibly up to days. These concepts are wrong: In addition to any translational regulation, metabolic alterations, such as an increase in the availability of insulin and glucose (51), or environmental stimuli such as exercise (52), can result in increases in gene transcription (not restricted to the so-called early response genes) within 1.53 h, even in adult human skeletal muscle. Thus the difference in the timescale between the adaptivity of transcription and the processes of protein turnover may be much less than previously thought. Skeletal muscle growth regulators such as IGF-1 and other regulatory factors, for instance cytokines, early genes, signal transduction proteins, and myogenic regulatory factors, are transcriptionally regulated in response to contractile overload induced by synergist ablation in rat. More microarray studies are needed to elucidate the behavior of genes during muscle growth in animals and humans. For more detailed reviews concerning the role of gene transcription in muscle hypertrophy, see Carson (53) and Baar et al. (54).

(fortsetzung folgt)
 
teil 4

Regulation of the Expression of the Specific Muscle Growth Factors IGF-1/MGF and Myostatin

Changing the availability of the muscle growth factors IGF-1/MGF and myostatin appears to be a central regulatory process in adaptive muscle growth. Obviously, IGF-1/MGF and myostatin are not directly regulated by stretch, overload, or muscle contraction but by the signal transduction pathways that sense these stimuli and consequently regulate the availability of these muscle growth factors for receptor binding. The protein availability depends on transcriptional regulation, translational regulation, splicing, localization, concentration of binding proteins, and proteolysis. The major regulatory step controlling the availability of IGF-1/MGF and myostatin in response growth-inducing stimuli appears to be transcriptional regulation. The transcriptional regulation of these factors involves some of the muscular signal transduction pathways mentioned above, as well as some developmental pathways and anabolic and catabolic steroid hormones.


REGULATION OF MYOSTATIN EXPRESSION Myostatin [growth/differentiation factor-8 (GDF-8)] is a member of the transforming growth factor- (TGF-) family (55). Depending upon the site of deletion in the myostatin gene, mice expressing the modified gene in muscle may exhibit either myofiber hyperplasia or hypertrophy (see 56 for references). Myostatin-null mice were, paradoxically, shown to be more susceptible than wild-type mice to hindlimb suspension-induced muscle atrophy (57). Myostatin expression is environmentally modifiable, i.e., it can be decreased during reloading but, oddly, it is unchanged during suspension-induced muscle atrophy hindlimb suspension (58). The regulation of myostatin expression appears to depend on major growth pathways. Binding sites for glucocorticoids, androgens, thyroid hormone receptors, myogenic differentiation factor 1, MEF2, PPAR, and NF-B, with appropriate positive and negative effects, have all been predicted for the myostatin promoter region and for glucocorticoids experimentally confirmed in human muscle (59, 60).


REGULATION OF IGF-1/MGF EXPRESSION In hypertrophying rodent muscle, IGF-1 mRNA rises nearly threefold within two days of functional overload and remains elevated thereafter (61), a phenomenon also observed in human skeletal muscle after a single resistance training bout (62). The increase in IGF-1 immunoreactivity was localized mostly within the fibers of rat anterior tibialis muscle four days after an eccentric-resistance training program that led eventually to hypertrophy (63), suggesting that pretranscriptional regulation is probably involved somehow in the exercise-induced increase. IGF-1 superfusion onto muscle in free-moving rats produces hypertrophy (64), and a similar maneuver rescues immobilized muscle from aging-associated sarcopenia (65), as does IGF-1 overexpression (66). The increase in IGF-1 and its splice variant MGF (IGF-1Eb) (see below) in skeletal muscle in response to mechanical loading may be regulated transcriptionally in rat muscle. However, the mechanisms that regulate MGF expression in response to an increase in muscle tension are currently unknown. Skeletal muscle IGF-1 expression increases in response to growth hormone and testosterone and decreases in response to glucocorticoid hormones, TNF, and interleukin-1 (67).


Specific Muscle Growth Regulation

Muscle growth stimuli lead to the activation of a signal transduction network and to a changed availability of the major muscle growth factors IGF-1/MGF and myostatin. The activated signal transduction pathways and changed growth factor availability will then regulate the activity of "muscle growth executors," which are the translational or protein synthesis machinery and satellite cells.


TRANSLATIONAL REGULATION The cellular and molecular mechanisms regulating the translation of mRNA in muscle have been elucidated to a much higher degree (68) than those regulating protein breakdown, partly because the protein/synthetic machinery forms a cohesive metabolic unit centered around the ribosome and the endoplasmic reticulum. There are a number of systems for achieving proteolysis, such as the ATP and ubiquitin-dependent proteasome (69), the lysosome, at least two cytoplasmic systems activated by various concentrations of Ca2+ (70), and even extracellular, lymphocyte-based systems, which act on muscle (71). There is good evidence that the myofibrillar apparatus is degraded by the proteasome; however, abundant amounts of proteasome mRNA or proteasome do not automatically produce an increase in proteolysis. For example, there are cases of paradoxical changes of proteasome activity in muscle in response to starvation and refeeding (72).

It is relatively easy to demonstrate regulatory changes in the machinery of protein synthesis, which are consonant with an increase in the synthesis of protein, e.g., ribosome, aggregation (73), whereas in the case of protein breakdown, changes in apparent activity of key components of the system may exist with no, or apparently opposite, changes in the extent of net protein balance. This has made it difficult to make much progress in understanding the physiological modulation of muscle protein breakdown, although some knowledge of the involvement of elements of signaling pathways also involved in regulation of protein breakdown is now being accumulated (70).

The mechanisms regulating translational regulation during muscle growth are becoming increasingly clear (see 7476 for more details). IGF-1 is capable of promoting muscle growth by activating regulators of translational initiation or efficiency via the PI3K-PKB/AKT-mTOR pathway (76, 77). IGF-1 treatment leads to an increased phosphorylation of PKB/AKT, mTOR, GSK3, and the translational regulators 4E-BP1 and p70S6k. When phosphorylated, 4E-BP1 detaches from eIF4E (78) (a translational initiation factor that mediates mRNA binding to the ribosome) and this initiates translation. Phosphorylated p70S6k promotes the increased translation of those mRNAs with a 5'-tract of pyrimidine (TOP), i.e., a series of cytosine or thymine repeats at the 5' gene terminus (79). All known ribosomal proteins have a TOP sequence, suggesting that mTOR regulates both ribosomal biogenesis and translation via p70S6k and 4E-BP1, respectively.

The main response of mTOR-dependent signaling occurs with a latency of only a few hours after growth-stimulating exercise. Hernandez et al. reported increases in PI3K and the translational regulator p70S6k occurring after 6 to 24 h and protein synthesis itself rising 12 to 24 h after resistance exercise in rat muscle (80). Similar results are available for human muscle (81). Rat muscles stimulated at high-frequency show p70S6k phosphorylation peaking at 3 to 6 h after stimulation, with some increased phosphorylation still apparent 36 h later in hypertrophying muscles (54). The delay in the activation of translational pathways and protein synthesis might be explained by the time necessary for strain-sensing and signaling, possibly via IGF-1 or MGF synthesis and secretion.

However, a recent paper shows that translational pathways and regulators are also transiently activated within 510 min after resistance exercise in rats (81a). This finding is interesting because a changed IGF-1 or MGF availability is unlikely to occur minutes after the stimulus and thus suggests other connections between the signal transduction pathways that sense resistance exercise signals and the translational regulators.

Essential amino acids stimulate protein synthesis via a nutrient-sensitive complex of two proteins, Raptor and mTOR, which, in humans, are expressed more in skeletal muscle than in other tissues (82, 83). It is likely that the Raptor-mTOR complex is destabilized and mTOR and the downstream translational regulators are activated when essential amino acid availability increases. An additional positive regulator, GL, appears to be involved (83). The binding of GL to mTOR strongly stimulates the kinase activity of mTOR toward S6K1 and 4E-BP1, an effect reversed by the stable interaction of Raptor with mTOR. The availability of essential amino acids sensed by this protein complex activates mTOR, as well as of the translational regulators eIF2, 4E-BP1, and p70S6k (84), which explains the observed stimulatory effect on protein synthesis.

In contrast, an increased energy demand (reflected by lowered ATP/ADP ratio, higher AMP, and lower creatine phosphate concentrations) leads to a depression of protein synthesis (85). A recently discovered interaction between AMPK and PKB-mTOR signaling in muscle has provided a possible mechanism for this effect: AMPK is activated by AMP and inhibited by ATP and creatine phosphate and is involved in the regulation of numerous cellular functions such as mitochondrial biogenesis and fuel metabolism (18, 86). Treatment of rats with the AMPK-activator, AICAR, resulted in a reduction in skeletal muscle protein synthesis. This was accompanied by a decreased activation of PKB-mTOR and its downstream targets p70S6k and 4E-BP1 (87).

(fortsetzung folgt)
 
teil 5

Regulation of Satellite Cell Proliferation and Differentiation

Muscle fibers are permanently differentiated; therefore, they are incapable of mitotic activity to produce additional myonuclei in times of increased protein synthesis and muscle growth (88). Yet, myonuclear number increases during skeletal muscle hypertrophy, thereby maintaining the myonuclear domain (the amount of sarcoplasm managed by a single myonucleus) (89). The predominant source of the additional myonuclei is satellite cells that are localized in indentations in the sarcolemma beneath the basal lamina (90). Less commonly, satellite cells may possibly fuse with each other to form new fibers (hyperplasia) (90).

The requirement of satellite cell activation for muscle hypertrophy was first demonstrated by a "nontransgenic knockout" approach in which mild -irradiation (which damages DNA while leaving other cellular machinery intact) was employed to block satellite cell proliferation. In response to functional overload, myonuclear number or muscle size was not increased in irradiated rat muscles (91). Adams and coworkers found that most of the hypertrophy potentially achievable during mechanical overload was prevented by similar treatment for four months (92). Thus it is likely that neither endogenous mesenchymal stem cells nor extramuscular (e.g., bone marrow) stem cells contribute much to the stem cell population of overloaded muscles, and the proliferation and fusion of existing satellite cells are responsible for the full load-induced increases observed in the muscle mass.

The limited proliferative capacity and the decrease in satellite cell number during normal aging may be implicated in atrophy and poor regeneration in elderly subjects (93). The number of satellite cells is thought not to be limiting to hypertrophy in normal human skeletal muscle, even in the elderly, although it may be in chronic users of anabolic steroids (94). Numerous growth factors have been shown to increase satellite cell proliferation. Here we focus on the key muscle growth regulators IGF-1 and myostatin. The effects of IGF-1 on muscle growth are pleiotrophic, activating satellite cell proliferation by spurring progression through G1 to S phase, increasing protein synthesis, decreasing protein degradation, and decreasing apoptosis. The mechanism by which IGF-I signals satellite cells to proliferate is by a decrease in p27Kip1 protein concentrations via activation of the phosphatidylinositol 3'-kinase (PI3K)/protein kinase B (PKB/Akt) signaling (95). As a result, increased p27Kip1 inhibits cyclin-dependent kinase 2 (cdk2), producing a late G1 arrest in the satellite cell cycle.

Myostatin inhibits both satellite cell proliferation and differentiation. Myostatin halts the satellite cell cycle by upregulating p21, which inactivates cyclin-dependent kinase activity so that retinoblastoma protein is particularly dephosphorylated (96). Myostatin also regulates satellite cell differentiation by inhibiting the expression of the myogenic growth factor, MyoD, via Smad 3 signaling (97). Reciprocally, MyoD upregulates myostatin to control myogenesis during the G1 phase of the cell cycle (at least in C2C12 myoblasts) (98).


SUMMARY OF REGULATORY MECHANISMS PRODUCING MUSCLE HYPERTROPHY Resistance exercise and most other muscle growth factors lead to the activation of a signal transduction network that will regulate the expression of the muscle growth factors IGF-1, MGF, and myostatin. The activated signal transduction pathways and the changed receptor binding of IGF-1, MGF, and myostatin lead to the activation of translation or protein synthesis and satellite cell proliferation and differentation, resulting in muscle growth. Blocking any one of these signal transduction pathways or factors may limit hypertrophy. However, it is incorrect to conclude that the blocking of hypertrophy by a single pathway or factor supports the conclusion that only one mechanism accounts for all of the resistance exercise or strain-induced hypertrophy of skeletal muscle. Likewise, enhancement of resistance exercise or strain-induced hypertrophy by a single factor should not be interpreted to mean that this factor alone is the means whereby increased mechanical load signal are transmitted to muscle growth physiologically. Indeed, the normal physiological response to produce the full potential hypertrophy during a load-induced growth of skeletal muscle involves the orchestration of multiple, simultaneous, and temporarily related sequential signals.


(fortsetzung folgt)
 
teil 6

ADAPTATION OF THE HUMAN MUSCLE MASS

The second part of this review is focused on observed changes in human MPS and breakdown and on translational and transcriptional control mechanisms, insofar as they act in adult human skeletal muscle, with particular reference to the effects of nutrition and physical activity.


EFFECTS OF NUTRITION ON SKELETAL MUSCLE PROTEIN MASS

The influences of food on protein metabolism are separable into two parts: those brought about through an increase in amino acid availability (e.g., the amino acidactivation of translational regulators via the Raptor-mTOR complex discussed above) and those resulting from increases in the concentration of hormones and growth factors (principally insulin and growth hormone/IGF-1) produced after stimulation by dietary secretogogues (e.g., glucose and amino acids).

Effects of Amino Acids

The discovery of the Raptor-mTOR complex and its likely function as an amino acid sensor (see above) has provided a likely explanation for the known stimulatory effect of amino acids on translation and protein synthesis. Here we review human studies in which the authors investigated this relationship in order to provide information that can be practically applied by those that wish to increase MPS in athletes, the elderly, or patients in whom muscle atrophy has occurred because of diminished protein synthesis. We aim to inform about effective amino acid concentrations, timings of ingestion, and the combination of amino acid feeding with resistance exercise.


MUSCLE PROTEIN SYNTHESIS An increase in the supply of amino acids to skeletal muscle (in many in vitro and in vivo models) stimulates the incorporation of tracer amino acids into protein (74). This effect can be observed independently of any hormones, although insulin may enhance it (see below). In human subjects, intravenous infusion of mixed amino acids doubles the incorporation of stable-labeled tracer amino acid into anterior tibialis muscle without any increase in the availability of insulin (99). Modulation of MPS via availability of amino acids appears to show a sigmoidal relationship; rises and falls in amino acid availability cause rapid changes in MPS in the basal to postprandial range, with a shallower slope at the upper and lower concentration limits (100, 101). In humans, the upper limit of amino acid concentrations at which MPS appears to be saturated is about 50% greater than the blood amino acid concentrations normally achieved after a meal (101). These and other recent data (109112) make a powerful point: The amount of amino acids necessary to stimulate MPS in the resting state and after exercise is in fact small (<10 g) compared with the accepted whole-body protein requirements (>70 g for most men).

In animal muscle, it is easily demonstrated that the branched chain amino acids (and leucine in particular) stimulate MPS in muscle cells in tissue culture, in perfused systems, and in intact mice and rats (102106). A similar effect has been observed in whole human beings; administration of boluses of single essential amino acids (including threonine, valine, phenylalanine, and leucine) but not non-essential amino acids (such as proline, glycine, serine, and alanine) markedly stimulated the incorporation of tracer-labeled amino acids into muscle protein (107). Could such a stimulation could be sustained in vivo? When large amounts of leucine were infused in human subjects, the intramuscular concentrations of other amino acids fell (108), presumably owing to stimulation of MPS (together with the possible inhibition by leucine of MPB). However, synthesis of protein requires all 20 physiological amino acids, and those that have the highest concentration ratio between muscle protein and the free pool will have the largest fall under situations of net anabolism unless transport from the blood occurs sufficiently quickly. Unfortunately, the capacity for muscles to continue to produce protein when the supply of all 20 amino acids is limited is not known.

Studies of the latency and duration of the effect of amino acids on MPS suggest that it takes 30 min for a stimulatory effect to be detected; thereafter the rate of increase is rapid, and peak rates are obtained within 60 to 90 min (101). Then MPS falls back to basal levels despite the continued abundant availability of amino acids, suggesting that the system is full of protein and is no longer responsive to nutritional stimulation. The extent of the refractory period before restimulation can occur and the identity of the mechanisms involved in the switch-off are unknown. When the limb arterio-venous exchange methods are applied, after increases in blood amino acid concentration, the apparent increase in net amino acid balance (and in model-derived values for MPS) is greater and occurs more quickly than the increase of the rate of tracer incorporation into muscle protein (13, 109, 110). There may be two reasons for this: First, amino acids may in fact be inhibiting MPB more rapidly than simulating MPS (although this seems unlikely given the results of previous studies) (111); or second, the apparent increase in the net protein balance may be because the muscle amino acid pool is overfilled. This latter possibility is acknowledged in a recent paper from the Galveston group (112). In any case, attributing arterio-venous concentration difference flow as signifying apparent increase in net protein balance should be regarded with caution under circumstances in which blood amino acid concentrations are changing; when arterial blood amino acid concentrations are rising (as after an oral dose of amino acids), there is a tendency to overestimate net muscle balance.

The cellular mechanisms involved are likely to be similar in human and animal muscle with stimulation of p70S6k and 4E-BP1 activation by amino acids (113).


MUSCLE PROTEIN BREAKDOWN Although there is no doubt that increasing amino acid concentrations by intravenous infusion, meal feeding, or ingestion of free amino acids increases MPS, inhibitory effects of amino acids on MPB, which are relatively easy to detect in animal muscles (70, 114), are, in human, beings absent or at least much less evident than those on MPS (115, 116). Some of the protein anabolic effects of a protein meal in vivo may possibly be modulated through the stimulation of insulin, with consequent inhibitory effects on muscle protein breakdown, but in our experience they are slight. Certainly, in the postexercise period increased availability of amino acids enhances MPS without having an effect on protein breakdown (111).

(fortsetzung folgt)
 
teil 7

Effects of Insulin

The effects of insulin on MPS in animals and humans may be different in terms of sensitivity and responsiveness. Much of the work demonstrating a marked stimulatory effect of insulin on MPS has been carried out in immature rodents or in only partially differentiated muscle cultured in vitro (117119), and it has been much harder to obtain consistent results demonstrating a coherent pattern of responsiveness in adult (especially human) MPS to insulin. Two main areas of contention concern the question of the extent of the human MPS response to insulin and the dose response characteristics of the system.


MUSCLE PROTEIN SYNTHESIS Barrett and coworkers (120, 121) first raised questions about the efficacy of insulin in human muscle when insulin was supplied to the forearm by close arterial infusion. No effects of insulin could be discerned on the disappearance of tracer into protein, i.e., protein synthesis, although there was a dose-dependent inhibition of protein breakdown. In this experimental model, protein metabolism in the forearm was assessed on the basis of arterio-venous balance of amino acids and the dilution across the arm of radio-labeled phenylalanine, an amino acid that is not subject to intermediary metabolism in muscle. However, the mathematical formula used by these workers produced results that may be underestimates of the rate of synthesis (see 122, 123 for discussion of this point). Also, Barrett and colleagues did not take muscle biopsies to check that the intramuscular concentration of amino acids was sufficient to sustain protein synthesis. Furthermore, as shown by Biolo and coworkers, when a different mathematical modeling approach was used for lysine and phenylalanine (a three- rather a than a two-pool model) (124), insulin could be shown to stimulate MPS. This conclusion was supported by independent data showing increased incorporation of stable tracer-labeled leucine into muscle protein sampled in the same period. Other workers have also demonstrated that insulin will stimulate MPS measured by incorporation or by limb arterio-venous difference exchangebut only when sufficient amounts of amino acids are present (116, 125127).

Nevertheless, there are still no data that adequately describe the dose-response relationship between MPS, measured unequivocally by means of tracer incorporation into protein, and the availability of insulin in blood. There is a pressing need for construction of a dose-response curve (carried out using somatostatin to inhibit basal insulin and with insulin added back systematically) that will simultaneously measure amino acid balance across the limb and tracer incorporation into muscle protein.


MUSCLE PROTEIN BREAKDOWN The effect of insulin on MPB has been well defined in terms of a decrease in the appearance of amino acids from preparations of muscle in tissue culture, in isolated whole muscles in perfused systems, and in measurement of arterio-venous tracer exchange in humans (116, 128). The major effect of insulin in inhibiting proteolysis appears to be modulated by effects on the proteasome, the ATP-ubiquitin-dependent proteolytic system that is responsible for myofibrillar protein breakdown in mammals (129). Despite a wealth of information describing alterations in mRNA and proteasome protein concentrations through manipulations of nutritional status, it has often been difficult to match up alterations in skeletal muscle balance or in measured protein breakdown with changes in the mRNA or proteasome content, e.g., in animals (72). In fact, no such parallel can be found from results of studies in human subjects as far as we are aware. In one well-designed study in which protein breakdown (measured as loss of amino acids from the limb) was elevated by three days of cortisol infusion, no changes occurred in the components of the proteasome pathway or their mRNA (130). A similar lack of correspondence between mRNA and protein for proteasome components and changes in net protein loss has been observed in muscle of lung cancer patients and in patients with acidosis due to renal disease (131, 132).

In short, after a meal and probably after exercise, the insulin-mediated decrease in MPB appears to be less important for the attainment of net anabolism than the stimulation of MPS.


Growth Hormone and Insulin-Like Growth Factor-1

Growth hormone has a number of metabolic actions on salt and water balance; fat metabolism; and, in growing animals and children, muscle and bone growth. Rennie recently reviewed the metabolic effects of growth hormone on human skeletal muscle and concluded that the balance of evidence suggests there are no major anabolic effects of exogenous rhGH in stimulating muscle protein accretion, muscle size, muscle strength, or muscle fiber characteristics in normal, healthy adult men or women, including the elderly (133). The published data, which have contributed to this conclusion, include information on incorporation of stable isotope-labeled amino acids into muscle and measurements of muscle mass and muscle fiber type using modern imaging and immunohistochemical methods.

There are, nevertheless, strong indications that IGF-1 involvement in metabolism may be locally important in skeletal muscle in humans and may modulate some of the effects of contractile activity in maintaining, or even increasing, muscle mass.

MGF is elevated in human muscle after exercise (134) but only in young (30-year-old) and not in old (75-year-old) subjects. One puzzling feature of this finding is that the MGF transcripts appear at concentrations that are very much lower than those of the IGF-1, so the effects of MGF must be because of different targeting or because the MGF is much more potent than IGF-1.

Although administration of IGF-1 seems to have acute stimulatory anabolic effects (135, 136) in muscle, long-term systemic administration of IGF-1 without its binding protein has no anabolic effect on lean body mass in elderly women (137), whereas a combination of IGF-1 with its binding protein 3 is markedly anabolic even in burn patients (138).


(fortsetzung folgt)
 
teil 9 und ende

Effects of Resistance Training on the Response of Muscle Protein Turnover

Many of the muscle metabolic systems show adaptations with habitual physical activity. Whether habitual physical activity results in a chronically altered rate of muscle protein turnover is currently the subject of some interest. In diabetic rats trained to perform resistance exercise, Farrell and coworkers demonstrated a reduced response of MPS to exercise after training (161). However, obtaining a clear answer to this question for human muscle is difficult. First, the residual effects of a previous bout of exercise, which may last up to 72 h, depend on intensity. Second, there is the problem of the habitual dietary intake of athletes who are subjected to much marketing and coaching information suggesting that they need to eat large amounts of protein in order to maintain or build muscle mass; this is a problem because habitually high rates of dietary protein intake lead to the induction of amino acid catabolic enzymes (particularly of the branched chain and aromatic amino acids) that decrease the deposition of dietary protein (162, 163). Until this effect abates (after reducing protein intake), there will be a tendency to exhibit negative nitrogen balance, so studies should not be conducted with rapid variation in dietary protein contents.

There is, in fact, little data on the subject in respect to MPS or even muscle mass. Studies of military recruits undergoing intense physical training suggest that there is a loss of body protein over the first few days of training but that adaptation rapidly occurs and nitrogen balance is restored, all at the same rate of dietary protein intake (164). Butterfield & Calloway found that in young men undergoing physical training, exercise increased the efficiency of protein utilization (165), i.e., trained subjects would require less protein. Partial validation of this position was provided by the first of two studies by Phillips and colleagues (166, 167). When two groups of subjects, one strength-trained and the other sedentary, were compared, there were no differences in resting post-absorptive MPS or MPB; also when the post-exercise responses to a single bout of pleiometric exercise at 120% of each subjects concentric 1 RM were compared, the rise in MPS in the trained subjects was 50% less than in the sedentary group, and there was no rise in MPB, which increased by about 40% in the untrained group. Thus net muscle balance (MPS minus MPB) was improved to the same extent in each group. However, a different result was obtained in a second longitudinal study of the effects of 8 weeks of resistance training in young previously untrained men, studied in the fed state at rest and also after a bout of exercise at 80% of their pretraining 1 RM (166). These results suggested that there was no difference in the response of the subjects in the trained and untrained state to acute exercise; also, rather oddly, the trained subjects did now show a marked increase in MPB as a result of exercise. In addition, basal rates of MPS and MPB were in fact now higher in the trained state; one consequence of this was that the effect of training seemed to decrease the relative response to exercise, a result that was consonant with the earlier findingsbut by a different mechanism! All in all, the data on net balance suggest that there was no effect of training tending to confirm the settled views of the present authors (143, 148) (although resisted by many athletes, their trainers, and, of course, sports nutrition companies) that habitual physical activity imposes no greater demands on protein requirements. As Phillips and coworkers (166) point out in their discussion, they did not test whether the same relative workload might affect protein turnover in trained and untrained subjects: It may be that if the above longitudinal studies had been conducted at the same relative intensity, a different result might have been obtained.

In the elderly, the rejuvenating effect of training may confound the issue. There is considerable controversy about whether aging is associated with a fall in muscle protein turnover [see (168) for review of this topic, which will not be dealt with further here]. However if it is true that the frail (as opposed to healthy) elderly show a fall in MPS, as seems likely, then exercise training may normalize it (169). The mechanism may be by decreasing the amount of TNF- in muscle (170).


Effects of Creatine on Human Muscle Protein Turnover

Dietary supplements containing creatine have become popular with athletes and trainers hoping to promote greater increase in muscle mass and strength in resistance training programs (171173). Measurements of myofibrillar protein synthesis (as incorporation of 13C leucine) and forearm protein breakdown (as dilution of deuterated phenylalanine) were unable to discern any differences in subjects studied before and after creatine supplementation, either in the post-absorptive or the fed state, at rest, or immediately after acute exercise (174, 174a). These results appear to rule out any acute effect of creatine alone on translation of pre-existing mRNA or on MPB but do not invalidate the possibility of transcriptional changes or satellite cell activation stimulated by creatine and physical activity.


Effects of Intensity of Contraction and Metabolic Power Output on Muscle Protein Turnover

It seems clear that maneuvers resulting in a relatively rapid rise in muscle mass are all associated with substantial increases, albeit after a short latency, possibly of about one hour, in MPS as a result of translational stimulation produced by changes in 4E-BP1 and p70S6k phosphorylation (176). These changes are followed, probably shortly thereafter, by transcriptional changes associated with intense exercise. Thus questions of the extent and temporal pattern of disturbance need to be addressed.

In human muscle, our group (M.J. Rennie, D.J.R Cuthbertson, K. Esser & M. Fedele, unpublished work) consistently observe a long-lasting rise in p70S6k phosphorylation after acute, high-intensity exercise, with smaller transient rises in PKB (Akt) phosphorylation, which are associated with a consistent rise in incorporation of tracer-labeled amino acid into muscle protein, whether myofibrillar or sarcoplasmic. We find no difference in the extent of stimulation of p70S6k or MPS in different quadriceps in which the same amount of force is applied during stepping exercise (one leg up, one leg down, while carrying 20% of body weight) to exhaustion (81). Because concentric exercise is energetically much less efficient than eccentric exercise and normally requires a higher rate of ATP turnover, this suggests that the crucial factor in determining the extent of the rise of MPS is force or intensity rather than ATP turnover, unless there is some threshold effect beyond which the rise in MPS remains constant.

However, paradoxically, when ATP turnover and the extent of quadriceps motor unit recruitment is kept constant during exercise at 60, 75, and 90% of 1 RM for different numbers of repetitions, the stimulation of MPS is constant (175).



CONCLUSION

As we have seen, our current ability to describe the adaptive responses of skeletal muscle to a wide variety of circumstances with changes in mass, composition, and function is impressive. The time resolution of techniques for measuring changes in muscle mass and composition and rates of protein turnover have increased such that we can now make robust measurements of the time courses of, for example, the rate of myofibrillar protein synthesis, which was impossible 10 years ago. Much information about the interrelationships between signaling pathways, which are important for transcriptional and translational regulation, has been accrued, and we have a much better understanding of the importance of satellite cells for growth and regeneration of muscle. There are, however, a substantial number of gaps that need to be filled. We still have no clear idea of the temporal relationship between the components of amino acid sensing and signaling to the processes of protein synthesis and breakdown and how these are affected by individual amino acids, insulin, and IGF-1. The exact pathways by which anabolic and catabolic steroids affect gene transcription and translation of mRNA remain obscure in human muscle despite the existence of response elements predicted for the muscle genes; the commonality (if any) of the pathways between myofibers and satellite cells is not at all well understood. The nature of the dichotomy of the responses to short-term, high-intensity exercise leading to hypertrophy and long-term low-intensity exercise leading to mitochondriogenesis and fast-to-slow fiber type transition remains a mystery. We still require a good description of the dose-response relationship between exercise intensities and the observed changes in mass and protein composition, and until we have these, it will be difficult to sort out the relative contributions of signaling pathways, their commonality, additivity, or independence from each other in controlling the adaptive responses of muscle.

Nevertheless, the increasing power of post-genomic techniques, particularly the use of transcriptional profiling and subsequent bioinformatics, should enable us to identify previously unknown means of controlling transcriptional and translational events. Perhaps some time in the next 10 years, our view will suddenly snap into focus, and it will become obvious how, for example, changes in the concentrations of Ca2+ or AMP can modulate the size and shape of muscle.


(es folgen noch die ACKNOWLEDGMENTS und 176 literaturangaben. ich bitte um verständnis, wenn ich sie nicht mehr hieherkopiere. wenn jemand ein literaturzitat wissen will, kann er es mir ja mitteilen)

gruß, kurt
 
Zuletzt bearbeitet:
Danke für die Mühe!

Werd mich durchackern.
 
Zurück
Oben